Companies / Actuate Therapeutics, Inc. / Activity
Activity — Actuate Therapeutics, Inc.
8 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 13, 2026 | Schmitt Daniel M CEO | Exercise | Common Stock | $0 | +272K | 272,055 1.14% of shares | low |
| Feb 13, 2026 | Schmitt Daniel M CEO | Other | Common Stock | $527.7K | -122K -44.80% | 150,181 0.63% of shares | low |
| Jan 5, 2026 | Thomson Todd S Director | Sell | Common Stock | $1.62M | -280K -23.63% | 904,795 3.78% of shares | medium |
| May 21, 2026 | Ronneberg Amy L Director | Grant | Stock Options | — | +15K | 15,000 0.06% of shares | low |
| Apr 1, 2026 | Schmitt Daniel M CEO | Grant | Employee Stock Option (right to buy) | — | +237K | 237,000 0.99% of shares | low |
| Apr 1, 2026 | Lytle Paul J Executive | Grant | Employee Stock Option (right to buy) | — | +105K | 105,000 0.44% of shares | low |
| May 21, 2026 | Thomson Todd S Director | Grant | Stock Options | — | +15K | 15,000 0.06% of shares | low |
| Feb 13, 2026 | Schmitt Daniel M CEO | Exercise | Restricted Stock Units | — | -272K -50.00% | 272,056 1.14% of shares | low |